Taiwan · Delayed Price · Currency is TWD Holy Stone Healthcare Company Description
Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan.
The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing.
It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcerative colitis; CA102N, a receptor-targeted chemotherapy that is in a Phase II trial for metastatic colorectal cancer, as well as in a pre-clinical stage for pancreatic ductal adenocarcinoma and a discovery stage for triple-negative breast cancer; ND108E, a CNS-targeted HA conjugate that is in a pre-clinical trial for Alzheimer’s disease; AMD112, a non-invasive HA-conjugated small molecule therapy that is in a pre-clinical trial for wet age-related macular degeneration and other neovascular retinal diseases; and HylCaryo, a hyaluronic acid (HA)-derived nanoparticle platform in a discovery stage.
In addition, the company engages in general investment; development and sale of medical devices; biotechnology services; and patent application for pharmaceutical products.
Holy Stone Healthcare Co., Ltd. was founded in 2001 and is headquartered in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Raymond Yang |
Contact Details
Address: No. 88, Neihu Rd. Taipei, 11493 Taiwan | |
| Phone | 886 2 8797 5966 |
| Website | hshc.com.tw |
Stock Details
| Ticker Symbol | 4194 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004194006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Raymond Yang | Chief Executive Officer |
| Bill Tang | President |
| Yuling Liu | Accounting Supervisor |
| Charles Hou | Chief Scientific Officer |
| Dr. M. Sherry Ku Ph.D. | Chief Scientific Advisor |